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Abstract : Background -The influence of cigarette smoking on the pathogenesis of
asthma in the elderly remains controversial. This study attempts to estimate longitudi-
nal changes in HRCT (high resolution computed tomography) parameters and pulmo-
nary function parameters obtained for ex-smokers and never-smokers in asthmatics
during 4-yr follow-up period.
Methods -Fourteen asthmatics (6 ex-smokers and 8 never-smokers) were studied
to determine the influence of aging and cigarette smoking on pulmonary function. and
mean lung density (MLO) and the relative area of the lung showing attenuation values
less than -950 HU (RA950) on HRCT scans.
Results -The values of FVC and FEV1 were significantly more decreased in asthmat-
ics without a smoking history during 4-yr follow - up period. The values of FVC, FEVI.
FEV1/FVC and OLeo/VA were significantly decreased and RV/TLC were significantly
increased in asthmatics with a smoking history over 4 years. and annual decline in
FEV1 ex - smokers was larger than that in never - smokers. In the upper lung field.
inspiratory MLO was observed to shift in a negative direction and inspiratory RA950
was found to increase during 4- yr observation period in ex - smokers. but not in
never-smokers. In the middle lung field, inspiratory RA950 was significantly enhanced
in both two groups. Although expiratory MLO. expiratory RA950 and exp RA950/ins
RA950 were observed to change significantly during the observation period in ex - smokers.
no changes were observed in never-smokers.
Conclusion - These results suggest that aging augments airspace enlargement pre-
dominantly in the middle lung field. while long term cigarette smoking further worsens
emphysematous alterations in the upper lung field.
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Introduction
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Methods
Asthma is considered a chronic inflammatory
disease of the airways with participation of com-
plex cellular and chemical mediators (l). It has
become evident that the repair of the chronic
inflammatory process can lead to various irre-
versible changes. Airway reconstruction, such
as bronchial wall thickening, bronchiectasis,
emphysematous changes, and mosaic patterns
of lung attenuation has been demonstrated by
high-resolution computed tomography (HRCf)
in patients with asthma (2,3).
Smoking is closely related to the onset mec-
hanism of COPD (4,5). It has been shown that
80-90% of all COPD patients have a history of
smoking (6), and patients with mild COPD can
reduce their symptoms by stopping smoking (7).
With regard to adult asthma, a recent case-
control study showed that adult onset of asthma
was not associated with a history of smoking
(8). In contrast, it has been demonstrated that
current smoking increases asthma severity (9),
and higher incidences of asthma are found in
current and former smokers, compared with
never-smokers (10-12). Our previous studies
using the relative area of the lungs showing at-
tenuation values less than -950 HU (RA950) on
high resolution Cf (HRCf) scans revealed that
HRCf lung densitometry was influenced by ag-
ing and smoking (13,14). However, to the best
of our knowledge, it remains unclear how the
long-term cigarette smoking influence on the
annual change of HRCf lung density as well as
pulmonary function parameters in asthma.
In the present study, we attempted to esti-
mate longitudinal changes in HRCf parameters
and pulmonary function parameters obtained for
ex-smokers and never-smokers in asthmatics
during 4-yr follow-up period.
SUBJECTS
Fourteen asthmatic subjects were recruited
from Misasa Medical Center. Among them, six
subjects (all males, mean age=64. 5±5. 7years ;
age at onset of the disease=51. 5±21. 0 years)
were ex-smokers with a history of smoking>20
years (32. 5±11. 7 pack-years). The remaining
8 patients (2 males and 6 females, mean age=
64. 4± 7. 6 years ; age at onset=55. 2 ± 10. 4
years) were never-smokers. Asthma was diag-
nosed according to the definition proposed by
the American Thoracic Society (15), as previ-
ously described (14). All asthmatic subjects
were stable with no changes in asthma symp-
toms and medication for at least 2 month before
pulmonary function tests and HRCf, except for
the use of short acting f3 2 agonists. Pulmonary
function tests and HRCf were annually per-
formed at nearly the same period of time.
Transitional variations of all parameters ob-
served for various tests of pulmonary function
and HRCf were assessed by estimating the an-
nual change in each parameter. The annual
change was calculated on the basis of the linear
regression equation constructed using longitudi-
nal data of each parameter obtained for each
subjects.
Serum IgE was measured by radioimmunoso-
rbent test (RIST) , and IgE antibodies specific
to 12 common aeroallergens including house
dust mite, pollens, moulds, and animal danders
were measured using the Pharmacia CAP system
(Pharmacia Diagnostics AB, Uppsala, Sweden).
Informed consent was obtained from all sub-
jects and the study protocol was approved by
the ethics committee of our institution.
PULMONARY FUNCTION TESTS
Pulmonary function tests were performed with
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a Chestac 33 (Chest Co., Tokyo, Japan). The
following measurements were performed on all
subjects: forced vital capacity (FVC), FEV}, and
FEV!/FVC. Total lung capacity (TLC) , func-
tional residual capacity (FRC) , residual volume
(RV) and RV/TLC were measured using the
helium dilution method. The DLco and DLco/
VA (alveolar volume) were measured according
to the single-breath technique. The FVC, FEV!
and FRC measurements for each patient were
expressed as a percentage of their predicted
values (%FVC, %FEV! and %FRC, respec-
tively) according to the prediction equations of
the Japanese Society of Chest Diseases (16).
DLco/VA was also expressed as a percentage of
the predicted values following the method of
Nishida (%DLco/VA). The ratio of FEV! to
FVC (FEV!/FVC) and RV to TLC (RV/TLC)
were expressed as percentages.
COMPUTED TOMOGRAPHY
All subjects underwent a non-contrast HRCT
scan of the lungs using a Toshiba Xpeed scan-
ner (Toshiba, Tokyo, Japan) with 2 mm colli-
mation, scanning time of 2.7 seconds, voltage
of 120 kVp, and current of 200 rnA. Maximal
inspiratory and maximal expiratory HRCT scans
were obtained at the following three selected
anatomic levels, as described by Miniati et al.
(17) : (l) top of the aortic arch, (2) origin of
the lower lobe bronchus, and (3) 3 cm above
the top of the diaphragm. The mean lung den-
sity (MLD) and the relative area of the lungs
with an attenuation value lower than -950 HU
(RA950) from each level were obtained both at
full inspiration and full expiration. The ratio of
expiratory RA950 to inspiratory RA950 (exp RA950
/ins RA950) was also calculated.
STATISTICAL ANALYSIS
Results are expressed as mean± SD. Statisti-
cally significant differences of the two values
were estimated using the unpaired Student's t
test and X 2 test. The difference in data at entry
and those at 4 years later was judged with the
paired t test. The significance of annual chan-
ges 0. e., changes in values against follow-up
time, which were determined with the linear re-
gression) in various parameters of pulmonary
function tests and HRCT parameters was esti-
mated on the assumption that the difference in
slopes conforms to the t distribution. A p value
of < 0.05 was regarded as significant.
Results
PATIENT CHARACTERISTICS AT ENTRY
Patient characteristics at entry are shown in
Table I. There were no significant differences
between ex-smokers and never-smokers in pa-
tient age and asthma duration. Serum IgE lev-
els and frequency of atopy did not differ signifi-
cantly between ex-smokers and never-smokers
in subjects studied. The values of %FVC, %FEV!
and FEV! /FVC were significantly larger in
never-smokers compared with ex-smokers (p<
O. 05). The RV/TLC value was significantly
larger in asthmatics with a history of smoking
than in never-smoking asthmatics (p<O. 05).
However the value of %FRC did not differ
significantly between the two groups. The
%DLco/VAwas significantly more decreased in
ex-smokers than in never-smokers in patients
with asthma (p< 0.05) (Table 1).
Initial inspiratory MLD values in three levels
and expiratory MLD values in the middle lung
field were significantly more negative in patients
with a smoking history than those in the never-
smokers. Initial inspiratory RA950 values in three
levels and expiratory RA950 values in the middle
lung field were significantly larger in patients
with a smoking history than those in the never-
smokers (Table 2).
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Table 3. Pulmonary function parameters at study entry and annual cangeges*
*Valuea are presented as mean and SD in parenthesis.
FVC = forced vital capacity; FEV I = forced expiratory volume in one second
FRC = functional residual capacity; RV = residual volume; TLC = total lung capacity
DLCO = diffuAing capacity oCthe lung for carbon monoxide; VA = alveolar volume
t Differing from zero (ie., Bicificant annual change, p <: 0.05)
t Differing from valuea fur neversmokers (p < 0.05)
FVC 2.56(0.43) -0.06 (0.03)' 2.63 (0.88) -0.18(0.13)1
FEV l 1.67 (0.44) -0.05 (0.03)' 1.36(0.64) '0.10 (0.05),·1
FEV1IFVC 65.1 (9.7) -0.46(0.81) 49.8 (11. I) '1.30 (1.l3)t
FRC 2.69 (0.59) 0.03 (0.30) 3.78(0.34) 0.01 (0.11)
RVfrLC 38.8(8.7) 0.89 (LSI) 49.6(6.4) 1.66 (l.34l
DLCONA 6.71 <2.19) 0.02 (0.10) 4.14 (0.97) -0,17 (0. 14)t
Table 1. Patient charaeteristice at entry to the study
A8thmatics
Neveramoken Ex"amoken
(0=8) (0=6)
Male/female. n 2ffl 6/0
Age, years (SO) 64.4(7.6) 646 (5.7) NS
Ace at onset, years (SO) 55.2 (10.4) 51.5(21.0) NS
Di&eaae duration, yean (SO) 9.2 (8.0) 13.0(15,9) NS
Serum ICE, IU/mi <ranee)· 127 (25-787) 159 (29-1 124} NS
Atopy/nonatopy, n
'14 313 NS
Smoking, pack'yean 0 32.5 (ll.7)
FVC,,,"pred (SO) 104.3 (21.0) 80.1 <25.6) p<O.05
FEVIo%pred (SO) 91.1 (29.2) 55.8 (22.8) p<O.05
FEV IIFVC, " (SD) 65.1 (9.7) 49.801.0 p<O.05
FRC.%pred (SO> 110.6 <29.6) 114.9(7.7) NS
RVfrLC, " (SO> 65.1 (9.7) 49.8 (11.0 p<O.05
DLCONA, "pred (SO) 137.2 (38.5) 90.2 (17..() p<O.05
Initial
Neversmokers
Change (per
year) Initial
Ex-smokers
Change (per
year>
Values are presented as mean and SO in parenthesis
+: eeometric mean and range in parenthesis.
FVC = forced vital capacity; "pred = percentare of the predicted value
FEV I = forced expiratory volume in one aecond
FRC = functional residual capacity; RV = residual volume; TLC = total lung capacity
DLCO = diffusing capacity of the lunc for carbon monoside; VA = alveolar volume
Table 2. HRCT parameters at entry to the study
Aathmatics
Neversmokers Ex-smokers
(n=8) (n=6)
Upper June field linsp)
MLD (SO> -889(14) '922 (23) p<O.OI
RAg!lO(SO) 6.9(8.8) 33.3 (20.0) p<O.OI
Middle lung field (inap)
MLD (SO> '894(16) -921 (12) p<O.Ol
RA".,(SO) 12.7(10.2) 33.3(11.3) p<O.OI
Lower lung- field (inap)
MLD (SO) '895(15) -922 (17) p<O.OI
RA,,,,(sO> 13.2(8.8) 34.0(15.0) p<O.OI
Middle lune field (exp)
MLO (SO> -85';(2<) -S91 (16) p<O.05
RA".,(SO) 2.8(5.9) 15.7(9.3) p<:O.05
Values are presented 8S mean and SD in parenthesi8
MLD = mean lung density
RA950 = the relative area oCthe lunp with an attenuation value lower than -950 HU
ANNUAL CHANGES IN PULMONARY FUNC-
TION PARAMETERS
The values of FVC and FEVl (p< 0 . 05)
showed significant annual changes in nonsmok-
ing asthmatics during 4-yr follow-up period
(Table 3). In asthmatics with a smoking history,
significant differences were observed in FVC,
FEVl , FEVl/FVC, RV/TLC and DLco/VA
(p<O. 05). Annual decline in FEVl was found
to be -0.05L/yr in nonsmoking asthmatics and
-0.10L/yr in asthmatics with a smoking history,
and the annual decline in ex-smokers was
larger than that in never-smokers (p< 0.05).
ANNUAL CHANGES IN MEAN LUNG DEN-
SITY OF HRCf IMAGES
During the 4-yr follow-up period, inspiratory
MLD in three levels did not change significantly
in never-smokers (Figure 1). In ex-smokers,
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Figure 1.
Fig. 1. Longitudinal changes in inspiratory MLD for
upper (uL). middle (ML). and lower (LL) lung fields
during 4-yr follow-up period. Open circle=never-
smokers with asthma, closed circle=ex-smokers
with asthma. Values are means±SD.•Significant
increase over 4 yr (p<O. 01).
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inspiratory MLD estimated in the upper lung
field shifted significantly negative direction (p<
0.01), but not in middle and lower lung fields.
Expiratory MLD at the middle portion of the lung
in ex-smokers was found to shift significantly in
a negative direction (p< O. OS), whereas that in
never-smokers did not show any significant
change (Figure 2).
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Fig.2. Longitudinal changes in expiratory MLD for
middle (ML) lung fields during 4-yr follow-up period.
Open circle=never-smokers with asthma. closed
circle=ex-smokers with asthma. Values are means
±SD. ·Significant increase over 4 yr (p<O. 05).
ANNUAL CHANGES IN RElATIVE AREA
WITH LOW AITENUATION OF HRCT IM-
AGES
Although significant increase in inspiratory
RA950 in the upper lung field was investigated for
ex-smokers (p<O. 01), upper lung inspiratory
RA950 for never-smokers was not altered during
follow-up period. (Figure 3). In the middle lung
field, inspiratory RA950 was significantly enhanced
in both two groups (p<O. OS). Inspiratory RA950
at lower lung region did not change over 4
years in never-smokers and ex-smokers.
Expiratory RA950 in the middle lung field exhib-
ited significant change in ex-smokers (p<O.OS).
whereas that in never-smokers showed no sig-
nificant change during the observation period
(Figure 4).
Figure 3.
Fig. 3. Longitudinal changes in inspiratory RA... for
upper (UL), middle (ML). and lower (LL) lung fields
during 4-yr follow-up period. Open circle=never-
smokers with asthma. closed circle=ex -smokers
with asthma. Values are means±SD.•Significant
increase over 4 yr (p<O. 01) ; +, "Significant in-
crease over 4 yr (p<O. 05).
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Figure 4.
Fig. 4. Longitudinal changes in expiratory RA... lur
middle (ML) lung fields during 4-yr follow-up period.
Open circle=never-smokers with asthma, closed
circle=ex-smokers with asthma. Values are mean
s±SD. 'Significant increase over 4 yr (p<O. 05).
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We also found that the value of exp RA950/ins
RA950 significantly moved to a positive value in
ex-smokers over 4 years, but not in never-
smokers (Figure 5).
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Figure 5.
Fig. 5. Longitudinal changes in exp RA950/ins RA950
during 4-yr follow-up period. Open circle=never-
smokers with asthma, closed circle=ex -smokers
with asthma. Values are means±SD.•Significant
increase over 4 yr (p< 0.05).
Discussion
To investigate the influence of long term ciga-
rette smoking on asthmatics, pulmonary func-
tion parameters and HRCT lung densitometry
(MLD and RA950 ) were followed for 4 years in
ex-smokers and never-smokers in patients with
asthma.
In efforts to minimize radiation exposure, we
calculated both MLD and RA950 using three
cross sections of the lung (upper, middle, and
lower). This was considered adequate as
Mishima et al described an accurate correlation
between the percentage of low attenuation area
(IAA) detected from 10 sections (from apex to
base of the lung) versus three sections in pa-
tients with COPD (18).
We used -950 HU as the cut-off level be-
tween the normal lung density area and IAA.
Previous studies have used variable levels rang-
ing from -900 to -960 HU (17-24). This dis-
crepancy may be attributed to variations
between the CT scanning techniques (equip-
ment & reconstruction of images) as well as CT
images (conventional vs. high resolution). In
our study, using HRCT of 15 healthy controls,
we found the mean MLD minus 1 SD to be
-949 HU.
Regarding the relationship between pulmonary
function and cigarette smoking, although no sig-
nificant correlation was found between the fre-
quency of lower respiratory illness (00) and
decrease in FEV, in sustained quitters, the
frequency of LRI had an adverse effect on the 5
-yr averaged annual rate of decline of FEV, in
intermittent and continuing smokers of patients
with mild COPD (7). In the present study,
FVC and FEV, were significantly more de-
creased in asthmatics without a smoking history
during 4-yr follow-up period, whereas RV/TLC
and %DLco/VA did not show any significant
change. We also observed that FVC, FEV!,
FEV,/FVC and %DLco/VA were significantly
decreased and RV/TLC were significantly in-
creased in asthmatics with a smoking history
over 4 years, and annual decline in FEV, ex-
smokers was larger than that in never-smokers.
The results suggested that cigarette smoking en-
hances hyperinflation and/or emphysematous
change of the lungs expressed by an increase in
RA950 in patients with asthma.
The relative area of the lungs with attenuation
values less than -950 HU (RA950 ) on HRCT
scans obtained at full inspiration has been
shown to be an objective measure of the extent
of pulmonary emphysema by comparison with
histopathologic data (20,21). Previous studies
have demonstrated that RA950 was significantly
larger in asthmatics with a smoking history
compared with those without a smoking history
(13). RA950 is also influenced by aging and dis-
ease severity in asthmatics without a smoking
history (14). Here, at the upper portion of the
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lung, inspiratory Mill was observed to shift in
a negative direction and inspiratory RA950 was
found to increase during 4-yr observation period
in ex-smokers, but not in never-smokers. In
contrast, at the middle and lower portion,
inspiratory MLD and RA950 did not show any
significant change. Although expiratory MLD,
expiratory RA950 and exp RA950/ins RA950 signifi-
cantly were observed to change during the ob-
servation period in ex- smokers, no changes
were observed in never- smokers. These results
demonstrated that the cigarette smoking influ-
enced on HRCT lung densitometry especially in
upper lung field and at full expiration.
In this study, we found RA950 at the middle
portion of the lung was significantly enhanced
over 4 years in nonsmoking asthmatics. Our
previous study suggested that MLD and RA950
are significantly correlated with pulmonary fun-
ction, patient age and disease severity in non-
smoking asthmatic patients (14). Soejima et al
(25) demonstrated that aging influenced air-
space enlargement predominantly in the middle
and lower lung field. The difference between
the findings of their study and ours may be due
to the fact that that our subjects are asthmatics
but not theirs.
In conclusion, HRCT is superior to pulmonary
function measurements in detecting subtle longi-
tudinal changes caused by aging and smoking
in asthma. These results suggest that aging
augments airspace enlargement predominantly in
the middle lung field, while long term cigarette
smoking further worsens emphysematous altera-
tions in the upper lung field.
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Changesoflungdensity
気管支噂息のlow attenuationare (LM )に対
する長期喫煙の影善一4年間の経過観察一
光延文裕,芦田耕三,保崎泰弘,柘野浩史,
岡本 誠,西田典数,永田拓也,高田真吾,
中井睦郎 l),谷崎勝朗,谷本光音2)
岡山大学医学部三朝医療センター内科,
放射線室l),岡山大学医学部第二内科2)
気管支嘱息患者の肺高分解能Cr所見に対する
長期喫煙の影響を検討することを目的とした｡非
喫煙嘱息患者8名,喫煙歴を有する嘱息患者6名
を対象として,肺機能,肺平均CT値 (MLD),-950
HU以下のlowatenuationarea(RA,50)について
4年間の経過観察を行った｡
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4年間の観察中,非喫煙職息患者では努力肺活
量,1秒量の低下を認めた｡喫煙歴を有する哨息
患者では努力肺活量,1秒量,1秒率,肺拡散能
の低下および残気率の増加を認めた｡喫煙歴を有
する嘱息患者では吸気において,上肺野MLDの
有意の低下,RA 95｡の有意の上昇を認めたが,非
喫煙職息患者では有意の変化は認めなかった｡中
肺野RA95｡は喫煙歴を有する職息患者,非喫煙嘱
息患者ともに有意の上昇を認めた｡また,呼気に
おいて,喫煙歴を有する瑞息患者でMLDの有意
の低下,RA,50の有意の上昇を認めたが,非喫煙
職息患者では有意の変化は認めなかった｡
嘱息患者において,加齢は主に中肺野のlowaト
tenuationarea,喫煙は上肺野のlow a仕enuation
areaに影響を及ぼすことが示唆された｡
